Veradigm Update Conference Call Summary Company Overview - **Company**: Veradigm (OTCPK:MDRX) - **Date of Call**: February 18, 2026 Key Points Strategic Objectives - The CEO outlined three strategic objectives: reset business strategy, recover market leadership with independent physician practices, and reignite profitable growth [4][10] - The "Reset, Recover, Reignite" plan is fully launched, with a focus on aligning with independent physician practices to strengthen retention and drive growth [4][10] Financial Performance - Revenue for 2025 is estimated to be between $584 million and $589 million, essentially flat compared to 2024, with a slight decline of 1% at the midpoint [19] - The Provider segment, generating the majority of recurring revenue, is estimated to have revenue between $463 million and $467 million, down 2% at the midpoint compared to the prior year [20] - The Payer and Life Sciences segment revenue is estimated to be between $121 million and $122 million, flat at the midpoint compared to 2024 [20] Operational Changes - Six low-revenue products will be discontinued to focus on growth bets with near-term revenue potential [5][41] - The company plans to broaden revenue cycle services and enhance its global R&D function, leveraging AI as a key growth driver [6][51] - A new Chief Product and Technology Officer was appointed to accelerate AI adoption in product development [6] Workforce and Organizational Changes - The company eliminated 15% of its workforce in 2025 to flatten organizational design and increase decision velocity [7] - Internal engagement survey results showed an increase in confidence in strategic direction from 68% to 84% after the company kickoff in January [9] Market Opportunities - The company launched integrated billing for Practice Fusion clients, addressing a significant demand among small practice clients [10] - New deals in the payer space, including a partnership with Sentara Health Plans, highlight the market opportunity with large health systems [12] - The life sciences business closed two deals with a total contract value exceeding $1 million, indicating growth potential in this segment [13] Cash Flow and Financial Health - The company remains net cash positive, with cash at $120 million and debt at $75 million as of year-end 2025 [21] - Cash decreased by $174 million during 2025, primarily due to non-typical items such as debt financing activities and legal fees [21][22] SEC Filing Progress - The company is working to get current and stay current with SEC filings, with the next major milestone being the filing of the 2023/2024 Super K [15][25] - The launch of new IT systems under Project Atlas is critical for improving data integrity and contract standardization [14][25] Future Outlook - The CEO expressed optimism about the growth potential in 2026, emphasizing the importance of aligning with independent practices and enhancing revenue cycle management [34][36] - The company aims to leverage AI to improve operational performance and client engagement, particularly in revenue cycle areas [50][53] Conclusion - 2026 is viewed as a critical year for Veradigm, with a focus on resetting the business strategy, recovering financial performance, and reigniting growth [16][88]